相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction
Arantxa Barandiaran Aizpurua et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D. Solomon et al.
CIRCULATION (2020)
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis
Matthew W. Segar et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure
Michele Correale et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)
Susan Stienen et al.
BIOMARKERS (2020)
Haemodynamic and metabolic phenotyping of hypertensive patients with and without heart failure by combining cardiopulmonary and echocardiographic stress test
Nicola R. Pugliese et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Asa K. Hedman et al.
HEART (2020)
Heart Failure With Preserved Ejection Fraction Separating the Wheat From the Chaff
Hector O. Ventura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Biological Versus Chronological Aging JACC Focus Seminar
Magda R. Hamczyk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Atrial Failure as a Clinical Entity JACC Review Topic of the Week
Felipe Bisbal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Research Priorities for Heart Failure With Preserved Ejection Fraction National Heart, Lung, and Blood Institute Working Group Summary
Sanjiv J. Shah et al.
CIRCULATION (2020)
Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
Jan Wintrich et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Ejection fraction in heart failure revisited-where does the evidence start?
Michael Boehm et al.
EUROPEAN HEART JOURNAL (2020)
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
Muthiah Vaduganathan et al.
EUROPEAN HEART JOURNAL (2020)
Characterization of theinflammatory-metabolicphenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease
Milton Packer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence
Marco Giuseppe Del Buono et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany
Sebastian Goebel et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Different Phenotype Characterization in PARAGON-HF An Unresolved Puzzle in Patients With HFpEF
Alberto Palazzuoli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2020)
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities
Giovanni Quarta et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction
Katlyn E. Koepp et al.
JACC-HEART FAILURE (2020)
Quantifying left ventricular function in heart failure: What makes a clinically valuable parameter?
Markus Borge Harbo et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial
Paul W. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction
Luigi Adamo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Heart failure management throughout the continuum
Hector O. Ventura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Implications of obesity across the heart failure continuum
Andrew Elagizi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Heart Failure With Preserved Ejection Fraction Infrequently Evolves Toward a Reduced Phenotype in Long-Term Survivors A Long-Term Prospective Longitudinal Study
Josep Lupon et al.
CIRCULATION-HEART FAILURE (2019)
Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
Maarten P. van den Berg et al.
EUROPEAN HEART JOURNAL (2019)
The continuous heart failure spectrum: moving beyond an ejection fraction classification
Filippos Triposkiadis et al.
EUROPEAN HEART JOURNAL (2019)
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure
Gianluigi Savarese et al.
JACC-HEART FAILURE (2019)
Differential Clinical Profiles, Exercise Responses, and Outcomes Associated With Existing HFpEF Definitions
Jennifer E. Ho et al.
CIRCULATION (2019)
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction?
Michele Senni et al.
CIRCULATION (2019)
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
Isabella Evangelista et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction
Yogesh N. V. Reddy et al.
EUROPEAN HEART JOURNAL (2019)
Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction
Fernando Telles et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Amil M. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
Yogesh N. V. Reddy et al.
CIRCULATION (2018)
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Scott D. Solomon et al.
CIRCULATION-HEART FAILURE (2018)
Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fraction
Jan F. Nauta et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study
Annamaria Iorio et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Lars H. Lund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Quality of inclusion criteria in the registered clinical trials of heart failure with preserved ejection fraction: Is it time for a change?
Hongxing Luo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Comparing Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure for Assessment of Left-Sided Filling Pressures
Yogesh N. V. Reddy et al.
JAMA CARDIOLOGY (2018)
Heart Failure With Preserved Ejection Fraction Expert Panel Report Current Controversies and Implications for Clinical Trials
Kishan S. Parikh et al.
JACC-HEART FAILURE (2018)
QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study
A. Andrea Pozzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
A comprehensive population-based characterization of heart failure with mid-range ejection fraction
Angela S. Koh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
What have we learned about heart failure with mid-range ejection fraction one year after its introduction?
Jan F. Nauta et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
An official European Respiratory Society statement: pulmonary haemodynamics during exercise
Gabor Kovacs et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a Pure Patient Phenotype and the Generalizability of Trial Findings
Hitesh C. Patel et al.
JOURNAL OF CARDIAC FAILURE (2017)
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes
Kevin S. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Epidemiology of heart failure with preserved ejection fraction
Shannon M. Dunlay et al.
NATURE REVIEWS CARDIOLOGY (2017)
Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction
Jasper Tromp et al.
JACC-HEART FAILURE (2017)
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction Association With Baseline Disease Severity and Subsequent Outcome
Erik B. Schelbert et al.
JAMA CARDIOLOGY (2017)
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction
Masaru Obokata et al.
CIRCULATION (2017)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Scott D. Solomon et al.
EUROPEAN HEART JOURNAL (2016)
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review
Muthiah Vaduganathan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Sherif F. Nagueh et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
Wynn G. Hunter et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Sanjiv J. Shah et al.
CIRCULATION (2015)
How do patients with heart failure with preserved ejection fraction die?
Michelle M. Y. Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction The Aldo-DHF Randomized Controlled Trial
Frank Edelmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Matchmaking for the Optimization of Clinical Trials of Heart Failure With Preserved Ejection Fraction
Sanjiv J. Shah
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?
Ross T. Campbell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
Michael R. Zile et al.
CIRCULATION (2011)
Digoxin treatment in heart failure - Unveiling risk by cluster analysis of DIG data
Sameer Ather et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION-HEART FAILURE (2010)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2009)
Diastolic dysfunction in heart failure with preserved systolic function:: Need for objective evidence -: Results from the CHARM echocardiographic Substudy CHARMES
Hans Persson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
John G. F. Cleland et al.
EUROPEAN HEART JOURNAL (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)
分享论文
